First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Stock Price Up 0.3% – Should You Buy?

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)’s stock price was up 0.3% on Tuesday . The company traded as high as $35.44 and last traded at $35.2950. Approximately 54,238 shares traded hands during trading, an increase of 509% from the average daily volume of 8,901 shares. The stock had previously closed at $35.18.

First Trust Nasdaq Pharmaceuticals ETF Stock Up 0.3%

The firm has a 50 day moving average of $33.69 and a 200 day moving average of $30.83. The firm has a market cap of $24.71 million, a price-to-earnings ratio of 14.51 and a beta of 0.54.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 31st. Investors of record on Friday, December 12th were issued a $0.1294 dividend. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date was Friday, December 12th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. NBC Securities Inc. lifted its holdings in First Trust Nasdaq Pharmaceuticals ETF by 33.0% during the fourth quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock valued at $44,000 after purchasing an additional 329 shares during the last quarter. Kestra Advisory Services LLC purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter valued at $59,000. Raymond James Financial Inc. bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the 2nd quarter worth about $57,000. Steph & Co. purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF in the third quarter valued at approximately $142,000. Finally, Flagship Harbor Advisors LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter valued at $205,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.